QuidelOrtho CorpQDEL
Price$10.38

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $2.7B-3.9% YoYTTM through 28 Jun 2026
Net Income -$1BTTM through 28 Jun 2026
Free Cash Flow -$211.2MTTM through 28 Jun 2026

Margins

Current
Gross Margin44.0%
EBITDA Margin-13.9%
Operating Margin-5.1%
Net Margin-39.2%

Returns

-5.0%ROE
-18.3%ROA

Balance Sheet Health

Debt / Equity1.55x
Current Ratio1.43x
Net Debt$2.6B
Cash & Equivalents$123.4M

Quality Metrics

Altman Z-Score-0.10
Piotroski F-Score2 / 9
FCF Margin-7.9%
Earnings-Beat Rate75.0%

Multi-Year Trend

Revenue
'21'22'23'23'24'25
FY2025: $2.7B
Diluted EPS-$15.43TTM
'21'22'23'23'24'25
FY2025: $-16.69

Dividend

No dividend

Capital Allocation

R&D Spend$180.9M
Capex Intensity5.8%
All values are periodic snapshots, not live quotes. Source dates are shown for reference.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.